FDA Chief Wants to Break Down Rare Disease Drug Monopolies

August 1, 2018

Patients battling rare diseases could have more treatment options under a Food and Drug Administration (FDA) plan to make clinical trials more efficient, which the agency head believes ultimately could lower drug prices.

Related Stories